Thermo Fisher Scientific Inc. (ETR:TN8)

Market Cap	182.06B
Revenue (ttm)	37.40B
Net Income (ttm)	5.62B
Shares Out	n/a
EPS (ttm)	14.81
PE Ratio	32.40
Forward PE	23.60
Dividend	1.50 (0.31%)
Ex-Dividend Date	Dec 15, 2025

Volume	150
Average Volume	153
Open	486.25
Previous Close	485.40
Day's Range	486.20 - 488.35
52-Week Range	336.25 - 590.90
Beta	n/a
RSI	47.92
Earnings Date	Jan 29, 2026

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1956
• Employees: 125,000
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: TN8

Financial Performance

In 2024, Thermo Fisher Scientific's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.

Financial numbers in USD